BDNF and metabolic dysfunction-associated steatotic liver disease: We employed a data mining analysis, an artificial intelligence approach, and revealed that “BDNF level ≥ 19.1 ng/mL and HbA1c ≥ 7.1%” is a profile for the high prevalence of reduced activity in patients with NAFLD.